View Item 

Show simple item record

National Drug Stockout Risks and the Global Fund Disbursement Process for Procurement
dc.contributor.authorGallien, Jérémie
dc.contributor.authorRashkova, Iva
dc.contributor.authorAtun, Rifat
dc.contributor.authorYadav, Prashant
dc.date.accessioned2017-06-16T20:12:28Z
dc.date.available2018-08-07T15:51:22Zen
dc.date.issued2017-06
dc.identifier.citationGallien, Jérémie ; Rashkova, Iva; Atun, Rifat; Yadav, Prashant (2017). "National Drug Stockout Risks and the Global Fund Disbursement Process for Procurement." Production and Operations Management 26(6): 997-1014.
dc.identifier.issn1059-1478
dc.identifier.issn1937-5956
dc.identifier.urihttps://hdl.handle.net/2027.42/137408
dc.publisherOxford University Press
dc.publisherWiley Periodicals, Inc.
dc.subject.otherAfrica
dc.subject.otherGlobal Fund
dc.subject.otheraccess to medicines
dc.subject.otherperformance‐based funding
dc.subject.otherglobal health financing
dc.titleNational Drug Stockout Risks and the Global Fund Disbursement Process for Procurement
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelIndustrial and Operations Engineering
dc.subject.hlbtoplevelEngineering
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137408/1/poms12662_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137408/2/poms12662-sup-0001-Appendix.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137408/3/poms12662.pdf
dc.identifier.doi10.1111/poms.12662
dc.identifier.sourceProduction and Operations Management
dc.identifier.citedreferenceThe Global Fund. 2012c. Price and Quality Reporting Database. Available at http://pqr.theglobalfund.org (accessed date October 15, 2012).
dc.identifier.citedreferenceTaylor, J. 2012. Density forecasting of intraday call center arrivals using models based on exponential smoothing. Management Sci. 58 ( 3 ): 534 – 549.
dc.identifier.citedreferenceTaylor, T. A., W. Xiao. 2014. Subsidizing the distribution channel: Donor funding to improve the availability of malaria drugs. Management Sci. 60 ( 10 ): 2461 – 2477.
dc.identifier.citedreferenceThe Global Fund. 2006. Quantification from a TB Perspective, Global Drug Facility. Technical Briefing Seminar, Copenhagen.
dc.identifier.citedreferenceThe Global Fund. 2009. Stock out episodes in Global Fund grants. Survey among Fund Portfolio Managers, January 2008–December 2009.
dc.identifier.citedreferenceThe Global Fund. 2011. Report of the Portfolio and Implementation Committee, 25th Board meeting, Ghana.
dc.identifier.citedreferenceThe Global Fund. 2012a. Who we are. Available at http://www.theglobalfund.org/en/about/whoweare/ (accessed date May 24, 2012).
dc.identifier.citedreferenceThe Global Fund. 2012b. Guidelines for completing the PR “ongoing progress update and disbursement request”, and LFA“ongoing progress review and disbursement recommendation”.
dc.identifier.citedreferenceThe Global Fund. 2012d. Disbursement in detail (raw data) and Grants in detail (raw data). Available at http://portfolio.theglobalfund.org/en/Home/Index (accessed date June 27, 2012).
dc.identifier.citedreferenceThe Global Fund. 2013. News Flash, Issue 16. Transition to annual grant disbursement. March 21, 2013. Available at http://www.theglobalfund.org/en/blog/31717/ (accessed date March 23, 2013).
dc.identifier.citedreferenceThe Henry J. Kaiser Family Foundation. 2012. U.S. Global Health Policy. Available at http://www.globalhealthfacts.org/data/topic/map.aspx?ind=30&by=Location (accessed date November 28, 2012).
dc.identifier.citedreferenceThe PLoS Medicine Editors. 2009. Time for a “Third Wave” of Malaria Activism to tackle the drug stock‐out crisis. PLoS Med. 6 ( 11 ): e1000188.
dc.identifier.citedreferenceTougher, S., Y. Ye, J. Amuasi, I. A. Kourgueni, R. Thomson, C. Goodman, A. G. Mann, R. Ren, B. A. Willey, C. A. Adegoke, A. Amin, D. Ansong, K. Bruxvoort, D. A. Diallo, G. Diap, C. Festo, B. Johanes, E. Juma, A. Kalolella, O. Malam, B. Mberu, S. Ndiaye, S. B. Nguah, M. Seydou, M. Taylor, S. T. Rueda, M. Wamukoya, F. Arnold, K. Hanson. 2012. Effect of the Affordable Medicines Facility–malaria (AMFm) on the availability, price, and market share of quality‐assured artemisin‐based combination therapies in seven countries: a before‐and‐after analysis of outlet survey data. Lancet 380: 1916 – 1926.
dc.identifier.citedreferenceUNDP. 2011. United Nations Development Fund. Pledge Guarantee for Health. Available at http://www.unfoundation.org/what-we-do/campaigns-and-initiatives/pledge-guarantee-for-health/our-work/ (accessed date January 4, 2013).
dc.identifier.citedreferenceUnited Nations. 2013. The Millennium Developement Goals Report. Available at http://www.un.org/millenniumgoals/pdf/report-2013/mdg-report-2013-english.pdf (accessed date February 12, 2014).
dc.identifier.citedreferenceWang, Y., B. Tomlin. 2009. To wait or not to wait: Optimal ordering under lead time uncertainty and forecast updating. Nav. Res. Log. 56: 766 – 779.
dc.identifier.citedreferenceWHO. 2004. The World Medicines Situation Report. WHO, Geneva.
dc.identifier.citedreferenceWHO. 2009. World Health Organization Maximizing Positive Synergies Collaborative Group. An assessment of interactions between global health initiatives and country health systems. Lancet 373: 2137 – 2169.
dc.identifier.citedreferenceWHO. 2013a. Global Tuberculosis Report. WHO, Geneva, Switzerland.
dc.identifier.citedreferenceWHO. 2013b. World Malaria Report. WHO, Geneva, Switzerland.
dc.identifier.citedreferenceYadav, P. 2007. Analysis of the public, private and mission sector supply chains for essential drugs in Zambia. Working paper.
dc.identifier.citedreferenceYu, D., Y. Souteyrand, M. Banda, J. Kaufman, J. Perriens. 2008. Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries? Global. Health 4 ( 8 ). doi: 10.1186/1744‐8603‐4‐8.
dc.identifier.citedreferenceALMA. 2011. African Leaders Malaria Alliance, evidence to policy initiative, clinton health access initiative. Maintaining the gains in malaria control. Country brief: Rwanda, September 2011.
dc.identifier.citedreferenceArlot, S., A. Celisse. 2010. A survey of cross‐validation procedures for model selection. Stat. Surveys 4: 40 – 79.
dc.identifier.citedreferenceAtun, R., F. M. Knaul, Y. Akachi, J. Frenk. 2012. Innovative financing for health: What is truly innovative? Lancet 380: 2044 – 2049.
dc.identifier.citedreferenceBerenguer G., A. Iyer, P. Yadav. 2016. Disentangling the efficiency drivers in country‐level global health programs: An empirical study. J. Oper. Manag. 45: 30 – 43.
dc.identifier.citedreferenceBrugha, R., M. Donoghue, M. Starling, P. Ndubani, F. Ssengooba, B. Fernandes, G. Walt. 2004. The Global Fund: Managing great expectations. Lancet 364: 95 – 100.
dc.identifier.citedreferenceBuzacott, J. A., R. Q. Zhang. 2004. Inventory management with asset‐based financing. Management Sci. 50 ( 9 ): 1274 – 1292.
dc.identifier.citedreferenceCelasun, O., J. Walliser. 2007. Predictability of aid: do fickle donors undermine economic development? 46th Panel Meeting of Economic Policy, Lisbon 2007.
dc.identifier.citedreferenceCenter for Global Development. 2013. Report: More health for the money. Available at http://international.cgdev.org/sites/default/files/More-Health-for-the-Money.pdf (accessed date February 12, 2014).
dc.identifier.citedreferenceChao, X., J. Chen, S. Wang. 2008. Dynamic inventory management with cash flow constraints. Nav. Res. Log. 55 ( 8 ): 758 – 7768.
dc.identifier.citedreferenceClaassen, M., A. Van Weele, E. Van Raaij. 2008. Performance outcomes and success factors of vendor managed inventory (VMI). Supply Chain Manag. Int. J. 13: 406 – 414.
dc.identifier.citedreferenceCohen, J., I. Singh, M. O’Brien. 2008. Predicting Global Fund grant disbursements for procurement of artemisin‐based combination therapies. Malaria J. 7: 200.
dc.identifier.citedreferenceFan, Y., D. Duran, R. Silverman, A. Glassman. 2013. Performance‐based financing at the Global Fund to fight AIDS, Tuberculosis and Malaria: An analysis of funding practice, 2002. Lancet Global Health 1: e161 – e168.
dc.identifier.citedreferenceFoster, S., R. Laing, B. Melgaard, M. Zaffran. 2006. Ensuring supplies of appropriate drugs and vaccines. D. Jamison, J. Breman, A. Measham, G. Alleyne, M. Claeson, D. Evans, P. Jha, A. Mills, P. Musgrove, eds. Disease Control Priorities in Developing Countries, 2nd edn. Oxford University Press, New York, 1323 – 1338.
dc.identifier.citedreferenceGallien, J., N. Leung, P. Yadav. 2016. Public distribution of essential medicines in Zambia: A heuristic, dataset, and validated simulation model. Working paper.
dc.identifier.citedreferenceGarnett, G., S. Cousens, T. Hallett, R. Steketee, N. Walker. 2011. Mathematical models in the evaluation of health programmes. Lancet 378: 515 – 525.
dc.identifier.citedreferenceGong, X., X. Chao, D. Simchi‐Levi. 2014. Dynamic inventory control with limited capital and short‐term financing. Nav. Res. Log. 61 ( 3 ): 184 – 201.
dc.identifier.citedreferenceHawkes, N. 2011. Gains in malaria control will be lost if funding stalls. Br. Med. J. 343: d5970.
dc.identifier.citedreferenceIHME (Institute for Health Metrics and Evaluation). 2014. Financing Global Health 2013: Transition in an Age of Austerity. IHME, Seattle, WA.
dc.identifier.citedreferenceKouvelis, P., J. Li. 2008. Flexible backup supply and the management of lead‐time uncertainty. Prod. Oper. Manag. 17: 184 – 199.
dc.identifier.citedreferenceKraiselburd, S., P. Yadav. 2011. Supply chains and global health: An imperative for bringing operations management scholarship into action. Prod. Oper. Manag. 22 ( 2 ): 377 – 381.
dc.identifier.citedreferenceLane, C., A. Glassman. 2008. Smooth and predictable aid for health: A role for innovative financing? Brookings Institution Global Health Financing Initiative working paper.
dc.identifier.citedreferenceLevi, R., G. Perakis, G. Romero. 2016. On the effectiveness of uniform subsidies in increasing market consumption. Management Sci. 63 ( 1 ): 40 – 57.
dc.identifier.citedreferenceLevine, R., J. Pickett, N. Sekhri, P. Yadav. 2008. Demand forecasting for essential medical technologies. Am. J. Law Med. 34: 225 – 255.
dc.identifier.citedreferenceLu, C., C. M. Michaud, K. Khan, C. Murray. 2006. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: Analysis of grant implementation. Lancet 368: 483 – 488.
dc.identifier.citedreferenceMinistry of Health, Uganda. 2012. Stock Status Report as at 1st November 2012. Available at www.health.go.ug/docs/ssr_nov_12.pdf (accessed date January 5, 2013).
dc.identifier.citedreferenceNatarajan, K. V., J. M. Swaminathan. 2014. Inventory management in humanitarian operations: Impact of amount, schedule, and uncertainty in funding. Manuf. Serv. Oper. Manag. 16: 595 – 603.
dc.identifier.citedreferenceOliynyk, I. 2011. Stock‐outs in Global Fund’s supported programs. Presentation, Workshop on Procurement and Supply Management of HIV and TB Products, Nairobi, Kenya.
dc.identifier.citedreferencePasquet, A., E. Messou, D. Gabillard, A. Minga, A. Depoulosky, S. Deuffic‐Burban, E. Losina, K. A. Freedberg, C. Danel, X. Anglaret, Y. Yazdanpanah. 2010. Impact of drug stock‐outs on death and retention to care among HIV‐infected patients on combination antiretroviral therapy in Abidjan, Cte d’Ivoire. PLoS ONE 5: e13414.
dc.identifier.citedreferenceRadalet, S., B. Siddiqi. 2007. Global Fund grant programmes: An analysis of evaluation scores. Lancet 369: 1807 – 1813.
dc.identifier.citedreferenceShretta, R., P. Yadav. 2012. Stabilizing supply of artemisinin and artemisinin‐based combination therapies in an era of wide‐spread scale‐up. Malaria J. 11: 399.
dc.identifier.citedreferenceSong, J. S. 1994. The effect of leadtime uncertainty in a simple stochastic inventory model. Management Sci. 40 ( 5 ): 603 – 613.
dc.identifier.citedreferenceSong, J. S., H. Zhang, Y. Hou, M. Wang. 2010. The effect of lead time and demand uncertainties in ( r, q ) inventory systems. Oper. Res. 58 ( 1 ): 68 – 80.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
poms12662_am.pdf
Size:
673.8KB
Format:
PDF
View/Open
Name:
poms12662-sup-0001-Appendix.pdf
Size:
2.736MB
Format:
PDF
View/Open
Name:
poms12662.pdf
Size:
487.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.